Orphanet: BERMES: Nuevo derivado de la Berberina para el tratamiento del Mesotelioma Maligno
x

Search for a research project

* (*) mandatory field

BERMES: Novel Berberine Derivative for the treatment of Malignant Mesothelioma

    • Type of research project :
      • Pre-clinical drug development / Drug delivery  
  • Website
  • Funded by an IRDiRC member
    • Funding body(ies) :
      • EUROPEAN COMMISSION - HORIZON 2020

Download more information on this project

  • Investigator of research project

  • Dr Carme PLASENCIA
  • Applied Research using OMIC Sciences
  • AROMICS
  • Calle Can Rosés 45
  • 08940 CORNELLÀ DE LLOBREGAT
  • SPAIN
  • More information
  • Phone  : 34 93 204 99 22
  • Fax  : 34 93 204 98 66
  • Website
  • Contact secretary :
Last update: April 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.